Blockade of the interaction with anti-IGFBP7 antibody similarly reduced tumor growth while promoting tumor vessel maturation, as evidenced by increased pericyte coverage and reduction in integrin β1/CD29 activation, a marker of EC destabilization and vascular leakiness. The gene discussed is IGFBP7; the disease is neoplasm.